Posts Tagged ‘Cataract’

How Mynosys is Gearing Up to Take on Femto

How Mynosys Is Gearing Up to Take on Femto

Now that Mynosys Cellular Devices has received FDA 510(k) clearance for its Zepto Capsulotomy System for cataract surgery, the company is planning its US launch August 1 and has partnered with Precision Lens of Bloomington, MN, to distribute the platform, Mynosys CEO John Hendrick tells OIS Weekly. Mynosys is based in Fremont, CA. Zepto takes…

Read More

What’s Next for Sun Ophthalmics After BromSite Launch?

What’s Next for Sun Ophthalmics after BromSite Launch? - OIS - Eye On Innovation Article - Healthegy

With the launch last week of BromSite to treat inflammation and prevent pain after cataract surgery, India-based Sun Pharma has taken a significant step in commercializing its strategy to build its branded ophthalmic drug business in the US. For development-stage companies in the US, that strategy could mean more licensing and partnership opportunities with the…

Read More

Carl Zeiss Meditec Taps Mazzo To Lead Consolidated Unit

OIS board member Jim Mazzo joins Carl Zeiss Meditec

Carl Zeiss Meditec has moved to consolidate its diagnostic and surgical products in ophthalmology and has brought in well-known ophthalmology industry veteran, James V. Mazzo, to head up the new unit. Mazzo joins CZM as Global President of the ophthalmology unit with responsibility for the new strategic business unit along with overseeing CZM’s US sales…

Read More

Surgeons Welcome Tecnis Symfony to Grow Premium Channel

Surgeons Welcome Tecnis Symfony to Grow Premium Channel - OIS - Eye On Innovation Article - Healthegy

With the FDA’s approval last week of Abbott Medical Optics’ Tecnis Symfony IOL (intraocular lens), cataract and refractive surgeons have a new alternative to monovision correction for presbyopes that they think will give the premium IOL channel a much-needed boost. Two and a half years after scrapping plans for its Synchrony accommodating IOL in the…

Read More

Avedro Plots Future of Corneal Cross-Linking

Just about two weeks after getting Food and Drug Administration (FDA) clearance for its corneal crosslinking platform, Avedro Chief Medical Officer Rajesh K. Raipal, MD, outlined the company’s next steps to advance its position in the crosslinking space during the Ophthalmology Innovations Showcase at OIS@ASCRS 2016. The FDA approved three components of the crosslinking platform:…

Read More

Alcon Looking at looking at EDOF and IOL Technology

Michael Onuscheck, global surgical franchise head for Alcon, a Novartis company, outlined the firm’s approach to innovation within the premium channel, which involves both internal development and external partnerships and acquisitions. In this decade, the focus of cataract innovation has shifted from safety, efficacy, and efficiency/throughput to refractive outcomes and meeting patients’ expectations with respect…

Read More

Abbott Medical Optics Points to Leadership Position

Over the past year, Abbott Medical Optics (AMO) has established a leading share position in the US PC-IOL market, driven by the new low-add-power Tecnis Multifocal IOLs. Outside the US, the early success of the Tecnis Symfony Extended Range of Vision IOL has also contributed to market share gains. A large European multicenter post-market study…

Read More

Bausch + Lomb Highlights Leadership in IOLs

Bausch + Lomb, a Valeant Pharmaceuticals company, remains the only firm with an FDA-approved accommodating IOL, the Crystalens AO. Andrew Chang, general manager and senior vice president of Bausch + Lomb US Surgical, highlighted clinical data from a study of long-term quality of vision and patient satisfaction with accommodating and multifocal IOLs conducted by John…

Read More

B&L’s Roberts Still Thinks Like a Doctor

Calvin Roberts, MD, CMO at Bausch & Lomb lends his physician’s perspective to how companies like Bausch & Lomb can serve eye care. Video Highlights 00:42 – I’m always asking what can we do for patient and what can we do for doctors? 01:00 – Think of all the things we do today for doctors…

Read More

Steinert Honored for His Career of Innovation

In a packed ballroom at the Intercontinental Hotel, OIS attendees recognized the achievements of one of ophthalmology’s physician-innovators. Roger F. Steinert, MD, was honored as this year’s OIS Lifetime Innovator Award. OIS Co-Chair Bill Link told attendees Steinert “had an impactful career” in ophthalmology. “Roger has been an innovator in our field from the beginning…

Read More

Heidelberg Makes Move into Cataract-Refractive Field

Heidelberg Engineering, which has more than 10,000 optical coherence tomography (OCT) units in place worldwide, is looking to help drive the premium channel by entering the cataract-refractive field with swept-source OCT imaging, Managing Director Kester Nahen, PhD, reported at OIS@ASCRS 2016. Heidelberg Engineering previewed its cataract and refractive imaging platform last year at the European…

Read More

Diagnostics Here to Stay

A panel of physicians and corporate leaders discuss the increasingly important impact diagnostics have on the premium channel. Topics included number of tests done, appetite of investors and interest of corporate partners. Video Highlights 00:20 How important are preoperative diagnostics in managing the premium channel. 00:29 – Jay Pepose, MD, PhD, It’s very important. If…

Read More